Myelodysplastic Syndrome
Myelodysplastic Syndromes (MDS) are a group of cancers in which blood-forming cells in the bone marrow become abnormal, leading to an insufficient supply of mature, healthy blood cells. Symptoms may include fatigue, shortness of breath, anemia, bleeding disorders, and frequent infections, with some types potentially progressing to acute myeloid leukemia.
Health Outcomes
- Accelerated Recovery of Chemotherapy-Induced Myelosuppression
- Altered Hematology Profile
- Changed Hematology Parameter
- Decreased Erythropoietin Responsiveness Index
- Decreased Serum IgM Levels at 60 Days
- Delayed Onset of Thrombocytopenia
- Developed Anemia
- Improved Blood Index
- Improved Engraftment
- Improved Erythroid Response
- Improved Hematological Biomarker
- Improved Hematological Health
- Improved Hematological Measure
- Improved Hematological Parameters
- Improved Hematological Profile
- Increased Cellular Apoptosis
- Increased Cobalamin Level
- Increased Dose Tolerance
- Increased Erythropoietin Level
- Increased Hemocyte Count
- Increased Mean Corpuscular Hemoglobin Level
- Increased Mean Corpuscular Volume
- Increased Risk of Acute Lymphoblastic Leukemia
- Increased Serum Iron Level
- Increased Vitamin B-12 Level
- Increased Vitamin B12 Concentration
- Increased Vitamin B12 Level
- Maintained Blood-Cell Counts
- Maintained Hemoglobin Level
- Prevented Malignant Transformation
- Prevention of Haematological Parameter Decline
- Reduced Acute Graft-Versus-Host Disease
- Reduced Anemia
- Reduced Basophil Count
- Reduced Chronic Graft-Versus-Host Disease
- Reduced Complete Blood Count
- Reduced Cytotoxic Lymphocyte Count
- Reduced Erythrocyte Count
- Reduced Erythropoietin-resistant Anemia
- Reduced Granulocyte Levels
- Reduced Hematocrit
- Reduced Hematological Index
- Reduced Hemocyte Apoptosis
- Reduced Immune Protection
- Reduced Immunoglobulin M Level
- Reduced Immunosuppression
- Reduced Monocyte Count
- Reduced Neutropenia Risk
- Reduced Neutrophil Activity
- Reduced Neutrophil Count
- Reduced Neutrophil-to-Lymphocyte Ratio
- Reduced Oxidative Stress in Red Blood Cells
- Reduced Packed Cell Transfusion
- Reduced Platelet Count
- Reduced Platelet Counts
- Reduced Red Blood Cell Transfusion Rate
- Reduced Reticulocyte Count
- Reduced Thrombocytopenia
- Reduced Total Leukocyte Count
- Reduced Transfusion Rate
- Reduced Transfusion Requirement
- Reduced White Blood Cell Count
- Reduced White Blood Cells After Lead Exposure
- Restored Blood Cell Levels